Security record · archived quarter
GSK
GSK plc · Healthcare · Drug Manufacturers - General
12Tracked holders
—Δ holders
118.47MShares held
$4.56BReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 118 | +2 | 291.90M | $15.17B | +8 | −5 |
| Q1 2026 | 116 | 0 | 315.42M | $17.28B | +8 | −8 |
| Q4 2025 | 115 | +4 | 328.16M | $15.98B | +4 | — |
| Q3 2025 | 18 | -1 | 242.57M | $10.47B | +1 | −3 |
| Q2 2025 | 17 | +1 | 220.73M | $8.48B | +2 | −1 |
| Q1 2025 | 14 | -1 | 157.56M | $6.11B | — | −1 |
| Q4 2024 | 15 | -1 | 135.53M | $4.59B | — | −1 |
| Q3 2024 | 15 | +3 | 120.78M | $4.99B | +3 | — |
| Q2 2024 | 12 | — | 118.47M | $4.56B | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 68.34M | — | $2.63B | 1.6% | n/c | 1 | SEC ↗ |
| 2 | Fisher Asset Management ✦ | 17.71M | — | $681.70M | 0.3% | n/c | 1 | SEC ↗ |
| 3 | PRIMECAP Management ✦ | 14.51M | — | $558.69M | 0.4% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 10.23M | — | $393.94M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 10.23M | — | $393.94M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Arrowstreet Capital ✦ | 2.58M | — | $99.28M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 2.35M | — | $90.40M | 0.2% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.06M | — | $79.47M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.06M | — | $79.47M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 2.06M | — | $79.47M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 2.06M | — | $79.47M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 2.06M | — | $79.47M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 2.06M | — | $79.47M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 465.83K | — | $17.93M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Tweedy, Browne ✦ | 109.86K | — | $4.23M | 0.2% | n/c | 1 | SEC ↗ |
| 16 | Millennium Management ✦ | 74.85K | — | $2.88M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 26.36K | — | $1.01M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 26.36K | — | $1.01M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 13.83K | — | $532,417 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2 holders, 16.10M shares, $459.30M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API